We work with traditional and genetically modified rodent models of human disease to support our Clients’ Drug Discovery and Development programs
Invivotek’s mission is to support drug discovery and pre-clinical development programs of our clients. We work with traditional and genetically modified rodent models of human disease. Our main product lines are evaluation of test therapeutics and phenotypic characterization of genetically modified rodents. We offer both custom and standard pre-clinical services. Our portfolio includes bioassays designed to support in vivo testing of potential therapeutics related to Immunology and Inflammation, Diabetes, Cardiovacular, Obesity, Neurodegenerative disorders, Cancer and other diseases. Invivotek’s in vivo testing capabilities are supported by biochemical and molecular biology techniques, as well as functional assays using primary cell cultures established from various mouse tissues under disease model and normal conditions. These assays provide tools to study mechanism of action of various test therapeutics or potential target genes and to explore drug efficacy biomarkers.